BRIDGEWAY CAPITAL MANAGEMENT, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 45 filers reported holding NEOS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$143,000
-11.2%
229,500
-24.6%
0.00%
-25.0%
Q3 2020$161,000
-33.7%
304,500
-14.1%
0.00%
-20.0%
Q2 2020$243,000
+85.5%
354,500
+102.6%
0.01%
+66.7%
Q1 2020$131,000
-58.7%
175,000
-16.7%
0.00%
-25.0%
Q4 2019$317,000
+1.9%
210,0000.0%0.00%0.0%
Q3 2019$311,000
+71.8%
210,000
+50.0%
0.00%
+100.0%
Q2 2019$181,000
-50.4%
140,0000.0%0.00%
-60.0%
Q1 2019$365,000
+1360.0%
140,000
+833.3%
0.01%
Q4 2018$25,000
-97.0%
15,000
-91.2%
0.00%
-100.0%
Q3 2018$825,000
+9.9%
170,100
+41.6%
0.01%0.0%
Q2 2018$751,000
-28.6%
120,100
-5.3%
0.01%
-27.3%
Q1 2018$1,052,000
+67.0%
126,800
+105.2%
0.01%
+57.1%
Q4 2017$630,000
+25.0%
61,800
+12.2%
0.01%
+16.7%
Q3 2017$504,000
+25.4%
55,1000.0%0.01%
+20.0%
Q2 2017$402,000
-30.2%
55,100
-31.1%
0.01%
-28.6%
Q1 2017$576,000
+23.1%
80,0000.0%0.01%
+16.7%
Q4 2016$468,000
-11.0%
80,0000.0%0.01%
-25.0%
Q3 2016$526,000
-12.8%
80,000
+23.1%
0.01%
-11.1%
Q2 2016$603,00065,0000.01%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders